Last updated on March 2018

Miglustat on Gaucher Disease Type IIIB

Brief description of study

evaluate the combination therapy with Miglustat and enzyme replacement therapy (ERT) on Gaucher disease

Detailed Study Description

understand if Miglustat (glucosylceramide synthase inhibitor) could improve neuropathy in patients with Gaucher disease

Clinical Study Identifier: NCT02520934

Contact Investigators or Research Sites near you

Start Over

Yin-Hsiu Chien, M.D., Ph.D.

National Taiwan University Hospital
Taipei, Taiwan

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.